New updates in COVID-19 research: Emerging therapeutic role of Fexofenadine and Montelukast. dr. Abhimanyu Uppal10 July 2021 5:47 AM GMTThe dawn of the year 2020 witnessed the surge of one of the biggest pandemics known to mankind. COVID-19 spread through continents affecting millions...
Post Covid-19 Recovery - Incidence of Pulmonary Sequelae - Hype or Fact? Dr Sravan Kumar4 Jun 2021 7:00 AM GMTCoronavirus disease 2019 (COVID-19) announced in March 2020 as a pandemic by the World Health Organization (WHO) with the causative agent of COVID-19...
All you need to know about DRDO's 2-Deoxy-D-Glucose drug Dr. Rahul Pandit18 May 2021 9:11 AM GMTAdding another leg to our battle against COVID19, the Government of India has introduced, a promising anti-COVID19 drug called 2-deoxy-D-glucose ...
Appropriate use of Remdesivir - know this better Dr. Rahul Pandit29 April 2021 7:00 AM GMTRepurposed drugs are an immediate response to an outbreak that has accelerated beyond the containment strategies during the COVID19 pandemic. They are ...
Amoxicillin - A reaffirmed First-Line Therapy in Common Infections Dr. Kamal Kant Kohli10 April 2021 6:32 AM GMTAmoxicillin is one of the most largely experienced, durably utilized antimicrobial agents in primary care settings (1). It remains a valuable choice...
Effect of Doxycycline on Cytokine Storm in COVID-19 Infection Dr. Kamal Kant Kohli21 Aug 2020 7:15 AM GMTRespiratory Infections and ARDSThe acute respiratory distress syndrome (ARDS) was described originally in 1967 by the late Dr. Thomas L. Petty and co...
Perspective: Managing COVID 19 ratifies the need for Palliative Care in medical curriculum Dr. Rajagopal1 Jun 2020 5:24 AM GMTThe following article has been jointly contributed by Dr M R Rajagopal, founder Pallium India and Richard SmithWhat is the duty of care of a doctor whe...
